SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · Real-Time Price · USD
15.14
-0.56 (-3.57%)
At close: Sep 15, 2025, 4:00 PM EDT
15.44
+0.30 (1.98%)
After-hours: Sep 15, 2025, 4:12 PM EDT
SI-BONE Market Cap
SI-BONE has a market cap or net worth of $653.15 million as of September 15, 2025. Its market cap has decreased by -4.94% in one year.
Market Cap
653.15M
Enterprise Value
552.31M
1-Year Change
-4.94%
Ranking
Category
Stock Price
$15.14
Market Cap Chart
Since October 17, 2018, SI-BONE's market cap has increased from $218.80M to $653.15M, an increase of 198.51%. That is a compound annual growth rate of 17.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 677.31M | 15.19% |
| Dec 31, 2024 | 587.97M | -30.84% |
| Dec 29, 2023 | 850.12M | 81.20% |
| Dec 30, 2022 | 469.15M | -36.93% |
| Dec 31, 2021 | 743.81M | -23.13% |
| Dec 31, 2020 | 967.59M | 79.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |